Cargando…
Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy
Photodynamic therapy (PDT) kills cancer cells by converting tumour oxygen into reactive singlet oxygen ((1)O(2)) using a photosensitizer. However, pre-existing hypoxia in tumours and oxygen consumption during PDT can result in an inadequate oxygen supply, which in turn hampers photodynamic efficacy....
Autores principales: | Cheng, Yuhao, Cheng, Hao, Jiang, Chenxiao, Qiu, Xuefeng, Wang, Kaikai, Huan, Wei, Yuan, Ahu, Wu, Jinhui, Hu, Yiqiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659941/ https://www.ncbi.nlm.nih.gov/pubmed/26525216 http://dx.doi.org/10.1038/ncomms9785 |
Ejemplares similares
-
Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles
por: Zhou, Zaigang, et al.
Publicado: (2018) -
Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles: Erratum
por: Zhou, Zaigang, et al.
Publicado: (2020) -
Perfluorocarbon regulates the intratumoural environment to enhance hypoxia-based agent efficacy
por: Wang, Wenguang, et al.
Publicado: (2019) -
Self-assembled IR780-loaded transferrin nanoparticles as an imaging, targeting and PDT/PTT agent for cancer therapy
por: Wang, Kaikai, et al.
Publicado: (2016) -
Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation
por: Qiu, Xuefeng, et al.
Publicado: (2017)